ERBB2 and neoplasm: CHAF1B mRNA expression is associated with negative oestrogen-receptor status [28] and is significantly lower in the luminal A breast cancer subtype in comparison with luminal B, HER2-positive, and basal-like subtype (BLC) tumours [27].